Pharma Services

Business

Guardian Pharmacy Services: Is the Stock Fairly Valued After Recent Gains?

A deep dive into Guardian Pharmacy Services (NYSE:GRDN) using a discounted cash flow model suggests its current share price is hovering close to its estimated intrinsic value. While the analysis provides a quantitative benchmark, investors are cautioned that valuation is just one piece of the puzzle in a complex and regulated healthcare sector.

Feb 2, 2026

Business

Sotera Health's Valuation Puzzle: Undervalued by DCF, Overpriced on P/E Amid Pharma Sector Scrutiny

Sotera Health's stock presents a valuation conundrum, with discounted cash flow analysis suggesting a 37% upside while its sky-high P/E ratio signals overvaluation. As investors reassess biotech and pharmaceutical services firms, the debate intensifies around SHC's true worth.

Feb 5, 2026

Business

Walmart Boosts Pharmacy Pay, Adds 3,000 Leadership Roles in Major Workforce Investment

In a significant move to bolster its healthcare services and retain staff, Walmart is creating thousands of new leadership positions and raising wages for pharmacy technicians across its U.S. stores.

Jan 31, 2026

Business

Bio-Techne Navigates Mixed Market Signals in Q2, Sees Strength in Pharma and APAC

Bio-Techne's Q2 FY2026 results show flat organic revenue, as robust demand from large pharmaceutical clients countered persistent softness in the biotech and academic sectors. Management highlights strategic growth areas and expects gradual market improvement.

Feb 4, 2026

Business

Aytu BioPharma Nears Crucial Profitability Threshold, Analysts Project 2028 Turnaround

After years of losses, Aytu BioPharma (NASDAQ: AYTU) is projected by analysts to reach breakeven by 2027 and post its first profit in 2028. The $27 million market-cap pharma firm faces a steep growth path and significant debt load on its journey to sustainability.

Feb 5, 2026

Business

Peoples Financial Services Boosts Dividend Payout, Signaling Confidence in Financial Health

Peoples Financial Services Corp. (NASDAQ: PFIS) announced a dividend increase to $0.625 per share, raising its yield to 4.5%. The move underscores the regional bank's decade-long commitment to shareholder returns and its robust earnings outlook.

Feb 5, 2026

Business

Markets Edge Higher Amid Mixed Signals: Jobs Slowdown Meets Resilient Services Sector

U.S. stock futures inched upward Thursday morning as investors parsed conflicting economic data: a sharp slowdown in private hiring against a steady expansion in the services industry, keeping rate-cut expectations in check.

Feb 5, 2026

Business

CDW Outperforms in Q4, Fueled by Cloud and AI Services Amid Diverse Market Demand

IT solutions giant CDW surpassed analyst expectations for Q4 2025, reporting $5.51 billion in revenue and highlighting strong growth in cloud, AI, and professional services as key drivers.

Feb 5, 2026

Business

Vertex Pharmaceuticals: A Deep Dive into Valuation After Recent Stock Pullback

Following a recent pullback, investors are scrutinizing whether Vertex Pharmaceuticals' (VRTX) current share price around $470 reflects its long-term cash flow potential. A discounted cash flow model suggests significant upside, while P/E ratios paint a more cautious picture, highlighting the complex valuation landscape for the biotech leader.

Feb 5, 2026

Business

EXL Clinches Fourth Consecutive 'Leader' Nod in Payer Digital Services Amid Market Turbulence

EXLService Holdings has been named a Leader in Payer Digital Transformation Services for the fourth straight year by ISG, even as its shares face significant near-term pressure. The recognition underscores its strong positioning in data, AI, and cloud solutions for U.S. healthcare payers.

Feb 5, 2026

Business

DaVita Hits Profitability Milestone in Integrated Kidney Care, Partners with Elara to Accelerate Home-Based Services

DaVita Inc. announces its Integrated Kidney Care (IKC) program has turned profitable for the first time, marking a significant shift in its value-based care strategy. Concurrently, a new partnership with home care provider Elara Caring aims to expand patient access to coordinated, home-based kidney services, positioning the company for renewed growth in a competitive landscape.

Feb 5, 2026

Business

Merck Shares Climb Despite Cautious Outlook, Drawing Cramer's Praise as a Pharma Favorite

Merck & Co. saw its stock rise over 2% following a solid quarterly earnings report, even as its full-year guidance came in softer than some expected. CNBC's Jim Cramer highlighted the pharmaceutical giant as a top pick in the sector, pointing to underlying strength beyond the headline numbers.

Feb 4, 2026

Business

Services Sector Keeps Expanding in January, But Inflationary Heat Remains a Concern

Two key surveys confirm the U.S. services industry maintained its growth momentum last month, fueled by rising employment and business activity. However, persistent price pressures and a dip in foreign demand signal ongoing economic headwinds that could delay interest rate cuts.

Feb 4, 2026

Business

The High Cost of Flexibility: 'Rent Now, Pay Later' Services Under Scrutiny

As housing costs soar, services that split rent into installments are gaining traction. But consumer advocates warn that the associated fees can translate into exorbitant effective interest rates, potentially deepening financial strain for vulnerable renters.

Feb 4, 2026

Business

Services Sector Hits Fastest Growth Since Late 2024, Bolstering Broad Economic Momentum

The U.S. services industry expanded at its quickest pace in months, according to the latest ISM data, mirroring a parallel surge in manufacturing activity and signaling underlying economic resilience despite persistent tariff pressures and inflation concerns.

Feb 4, 2026

Business

Cramer Sees Bright Spots for Oilfield Services Giant SLB Amid Policy Shifts

CNBC's Jim Cramer points to SLB as a potential beneficiary of renewed U.S. drilling focus, highlighting the oilfield services firm's strong recent performance and strategic positioning in the evolving energy landscape.

Feb 4, 2026

Business

Cramer Cools on Moderna's Rally, Prefers Other Pharma Bets Despite Stock Recovery

CNBC's Jim Cramer acknowledged Moderna's strong January performance but expressed caution, noting the company faces years of unprofitability and highlighting other pharmaceutical and biotech stocks he finds more attractive for investment.

Feb 4, 2026

Business

Europe's Pharma Fightback: How Tariffs and Tensions Are Fueling a Manufacturing Resurgence

Despite a shrinking global share and punitive trade policies, Europe is attracting renewed pharmaceutical investment. Companies are betting on its regulatory rigor, regional diversification strategies, and deep scientific heritage to secure future supply chains.

Feb 4, 2026

Business

CDW Outperforms in Q4, Driven by Cloud and Services Strength, Despite Market Headwinds

CDW Corporation closed its fiscal 2025 with a robust fourth quarter, surpassing expectations as customer focus on efficiency and security fueled growth in high-margin software, cloud, and services segments. While navigating a cautious IT spending outlook for 2026, the company aims to outpace the broader market.

Feb 4, 2026

Business

Republic Services Expands Midwest Footprint with Acquisition of Kansas Landfill and Recycling Facility

Republic Services, a national waste management leader, has moved to acquire a key landfill and material recovery facility in Kansas from Hamm Companies. The deal involves a site with decades of service history and notable technological adoption, marking another strategic consolidation in the industry.

Feb 4, 2026